← Mechanisms of action
Bcr/Abl fusion protein
CHIMERIC PROTEINHomo sapiens
Linked proteins
Drugs acting on this target (9)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| asciminib (Scemblix) | Antagonist | approved | Small molecule | Bcr/Abl fusion protein antagonist |
| asciminib (Scemblix) | Inhibitor | approved | Small molecule | Bcr/Abl fusion protein inhibitor |
| bosutinib (bosulif) | Inhibitor | approved | Small molecule | Bcr/Abl fusion protein |
| dasatinib (sprycel) | Inhibitor | approved | Small molecule | Bcr/Abl fusion protein |
| imatinib (gleevec) | Inhibitor | approved | Small molecule | Bcr/Abl fusion protein |
| nilotinib (tasigna) | Inhibitor | approved | Small molecule | Bcr/Abl fusion protein |
| Olverembatinib | Inhibitor | experimental | Small molecule | Bcr/Abl fusion protein inhibitor |
| ponatinib (iclusig) | Inhibitor | approved | Small molecule | Bcr/Abl fusion protein inhibitor |
| radotinib | Inhibitor | experimental | Small molecule | Bcr/Abl fusion protein inhibitor |